NSE hits new milestone with 22 crore investor accounts in April 2025

The National Stock Exchange has surpassed 22 crore investor accounts in April 2025 as digital access and retail interest continue to deepen market participation.

The National Stock Exchange has surpassed 22 crore investor accounts in April 2025 as digital access and retail interest continue to deepen market participation.

The management expects €500 million in annualised savings starting H2FY26, with the run-rate increasing to over €550 million in FY27.

Companies like Dr Reddy’s Laboratories, Cipla, Sun Pharmaceutical Industries, and Aurobindo Pharma could see pressure on their margins if tariffs are imposed.

CONCOR’s export-import (EXIM) volume growth also missed the company’s guidance of 15% by a long way, coming in at 6.8%.

Mittal’s appointment took effect from March 25, 2025, for a term of three years or until further orders, the bank said in its regulatory filing.

Friday’s rally, powered by strong global cues and broad-based buying, saw the Nifty jump 429 points to close at 22,829, while the Sensex rose 1,310 points to finish at 75,157. The Nifty Bank climbed 762 points to 51,002 and the…

The probe is being led by DGGI’s Coimbatore zone, which is currently examining whether Hajmola candy should be treated as an ayurvedic medicine attracting 12% GST or as a candy taxed at 18%.

This latest development follows a similar sale earlier in the week, where NBCC sold 1,185 residential units at Aspire Dream Valley Phase-III, Greater Noida, fetching around ₹1,504.69 crore.

US futures are swing wild swings between gains and losses on Friday after China raised its tariffs on US imports to 125% from 84% that it had announced on Wednesday.

At the conclusion of the inspection, the US FDA issued a Form 483, listing 11 observations. Aurobindo Pharma characterised these observations as “procedural in nature.”